Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Patient perceptions and preferences of biologic therapies in SLE.

Lim SS, Kan H, Pobiner BF, Bao G, Drenkard C.

Lupus Sci Med. 2019 Aug 12;6(1):e000322. doi: 10.1136/lupus-2019-000322. eCollection 2019.

2.

Update on lupus epidemiology: advancing health disparities research through the study of minority populations.

Drenkard C, Lim SS.

Curr Opin Rheumatol. 2019 Nov;31(6):689-696. doi: 10.1097/BOR.0000000000000646.

3.

Health service utilization among African American women living with systemic lupus erythematosus: perceived impacts of a self-management intervention.

Twumasi AA, Shao A, Dunlop-Thomas C, Drenkard C, Cooper HLF.

Arthritis Res Ther. 2019 Jun 25;21(1):155. doi: 10.1186/s13075-019-1942-7.

4.

Vicarious Racism Stress and Disease Activity: the Black Women's Experiences Living with Lupus (BeWELL) Study.

Martz CD, Allen AM, Fuller-Rowell TE, Spears EC, Lim SS, Drenkard C, Chung K, Hunter EA, Chae DH.

J Racial Ethn Health Disparities. 2019 Oct;6(5):1044-1051. doi: 10.1007/s40615-019-00606-8. Epub 2019 Jun 18.

PMID:
31215018
5.

Racial Disparities in Mortality Associated with Systemic Lupus Erythematosus - Fulton and DeKalb Counties, Georgia, 2002-2016.

Lim SS, Helmick CG, Bao G, Hootman J, Bayakly R, Gordon C, Drenkard C.

MMWR Morb Mortal Wkly Rep. 2019 May 10;68(18):419-422. doi: 10.15585/mmwr.mm6818a4.

6.

Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.

Chae DH, Martz CD, Fuller-Rowell TE, Spears EC, Smith TTG, Hunter EA, Drenkard C, Lim SS.

Am J Epidemiol. 2019 Aug 1;188(8):1434-1443. doi: 10.1093/aje/kwz105.

PMID:
31062841
7.

Chronic Cutaneous Lupus Erythematosus: Depression Burden and Associated Factors.

Hong J, Aspey L, Bao G, Haynes T, Lim SS, Drenkard C.

Am J Clin Dermatol. 2019 Jun;20(3):465-475. doi: 10.1007/s40257-019-00429-7.

PMID:
30877492
8.

Relationships among organ damage, social support, and depression in African American women with systemic lupus erythematosus.

Jordan J, Thompson NJ, Dunlop-Thomas C, Lim SS, Drenkard C.

Lupus. 2019 Feb;28(2):253-260. doi: 10.1177/0961203318815573. Epub 2018 Nov 27.

9.

Physician-patient interactions in African American patients with systemic lupus erythematosus: Demographic characteristics and relationship with disease activity and depression.

Drenkard C, Bao G, Lewis TT, Pobiner B, Priest J, Lim SS.

Semin Arthritis Rheum. 2019 Feb;48(4):669-677. doi: 10.1016/j.semarthrit.2018.05.012. Epub 2018 Jun 13.

10.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Reyes GL, Acosta Colman MI, Aquino AM, Mora-Trujillo CS, Muñoz-Louis R, García Valladares I, Orozco MC, Burgos PI, Betancur GV, Alarcón GS; Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR).

Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25.

11.

Depressive Symptoms Are Associated With Low Treatment Adherence in African American Individuals With Systemic Lupus Erythematosus.

Heiman E, Lim SS, Bao G, Drenkard C.

J Clin Rheumatol. 2018 Oct;24(7):368-374. doi: 10.1097/RHU.0000000000000794.

12.

Racial Disparities in the Incidence of Primary Chronic Cutaneous Lupus Erythematosus in the Southeastern US: The Georgia Lupus Registry.

Drenkard C, Parker S, Aspey LD, Gordon C, Helmick CG, Bao G, Lim SS.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):95-103. doi: 10.1002/acr.23578.

PMID:
29669194
13.

Geriatric Assessment of Physical and Cognitive Functioning in a Diverse Cohort of Systemic Lupus Erythematosus Patients: A Pilot Study.

Plantinga L, Tift BD, Dunlop-Thomas C, Sam Lim S, Barrett Bowling C, Drenkard C.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1469-1477. doi: 10.1002/acr.23507. Epub 2018 Aug 27.

14.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2017 Dec;76(12):2071-2074. doi: 10.1136/annrheumdis-2017-211814. Epub 2017 Sep 22.

PMID:
28939626
15.

Perceived stress and reported cognitive symptoms among Georgia patients with systemic lupus erythematosus.

Plantinga L, Lim SS, Bowling CB, Drenkard C.

Lupus. 2017 Sep;26(10):1064-1071. doi: 10.1177/0961203317693095. Epub 2017 Feb 23.

16.

External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus.

Brandt JE, Drenkard C, Kan H, Bao G, Dunlop-Thomas C, Pobiner B, Chang DJ, Jolly M, Lim SS.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):842-848. doi: 10.1002/acr.23009. Epub 2017 May 9.

17.

Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.

Plantinga L, Lim SS, Bowling CB, Drenkard C.

Lupus Sci Med. 2016 Jul 19;3(1):e000161. doi: 10.1136/lupus-2016-000161. eCollection 2016.

18.

Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.

Plantinga LC, Lim SS, Patzer RE, Pastan SO, Drenkard C.

BMC Nephrol. 2016 Jul 7;17(1):64. doi: 10.1186/s12882-016-0274-y.

19.

Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.

Pons-Estel GJ, Aspey LD, Bao G, Pons-Estel BA, Wojdyla D, Saurit V, Alvarellos A, Caeiro F, Haye Salinas MJ, Sato EI, Soriano ER, Costallat LT, Neira O, Iglesias-Gamarra A, Reyes-Llerena G, Cardiel MH, Acevedo-Vásquez EM, Chacón-Díaz R, Drenkard C.

Lupus. 2017 Jan;26(1):73-83. Epub 2016 May 26.

PMID:
27230554
20.

Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry.

Plantinga LC, Drenkard C, Pastan SO, Lim SS.

Lupus Sci Med. 2016 Jan 22;3(1):e000132. doi: 10.1136/lupus-2015-000132. eCollection 2016.

21.

Discrimination and Cumulative Disease Damage Among African American Women With Systemic Lupus Erythematosus.

Chae DH, Drenkard CM, Lewis TT, Lim SS.

Am J Public Health. 2015 Oct;105(10):2099-107. doi: 10.2105/AJPH.2015.302727. Epub 2015 Aug 13.

22.

Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry.

Plantinga L, Lim SS, Patzer R, McClellan W, Kramer M, Klein M, Pastan S, Gordon C, Helmick C, Drenkard C.

Arthritis Care Res (Hoboken). 2016 Mar;68(3):357-65. doi: 10.1002/acr.22685.

23.

Epidemiology of lupus: an update.

Lim SS, Drenkard C.

Curr Opin Rheumatol. 2015 Sep;27(5):427-32. doi: 10.1097/BOR.0000000000000198. Review.

PMID:
26196375
24.

Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.

Plantinga LC, Patzer RE, Drenkard C, Pastan SO, Cobb J, McClellan W, Lim SS.

BMC Nephrol. 2015 Mar 29;16:39. doi: 10.1186/s12882-015-0037-1.

25.

Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Drenkard C, Patzer RE, Klein M, Kramer MR, Pastan S, Lim SS, McClellan WM.

Arthritis Rheumatol. 2015 Mar;67(3):761-72. doi: 10.1002/art.38983.

26.

Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Plantinga LC, Patzer RE, Drenkard C, Kramer MR, Klein M, Lim SS, McClellan WM, Pastan SO.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):571-81. doi: 10.1002/acr.22482.

27.

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.

Ugarte-Gil MF, Acevedo-Vásquez E, Alarcón GS, Pastor-Asurza CA, Alfaro-Lozano JL, Cucho-Venegas JM, Segami MI, Wojdyla D, Soriano ER, Drenkard C, Brenol JC, de Oliveira e Silva Montandon AC, Costallat LT, Massardo L, Molina-Restrepo JF, Guibert-Toledano M, Silveira LH, Amigo MC, Barile-Fabris LA, Chacón-Díaz R, Esteva-Spinetti MH, Pons-Estel GJ, McGwin G Jr, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2015 Jun;74(6):1019-23. doi: 10.1136/annrheumdis-2013-204620. Epub 2014 Feb 13.

PMID:
24525909
28.

The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry.

Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C.

Arthritis Rheumatol. 2014 Feb;66(2):357-68. doi: 10.1002/art.38239.

29.

Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States.

Drenkard C, Bao G, Dennis G, Kan HJ, Jhingran PM, Molta CT, Lim SS.

Arthritis Care Res (Hoboken). 2014 Jun;66(6):878-87. doi: 10.1002/acr.22245.

30.

Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.

Drenkard C, Yazdany J, Trupin L, Katz PP, Dunlop-Thomas C, Bao G, Lim SS.

Arthritis Care Res (Hoboken). 2014 Jun;66(6):888-96. doi: 10.1002/acr.22231.

31.

Primary preventive services in patients with systemic lupus erythematosus: study from a population-based sample in Southeast U.S.

Drenkard C, Rask KJ, Easley KA, Bao G, Lim SS.

Semin Arthritis Rheum. 2013 Oct;43(2):209-16. doi: 10.1016/j.semarthrit.2013.04.003. Epub 2013 May 31.

PMID:
23731530
32.

Benefits of a self-management program in low-income African-American women with systemic lupus erythematosus: results of a pilot test.

Drenkard C, Dunlop-Thomas C, Easley K, Bao G, Brady T, Lim SS.

Lupus. 2012 Dec;21(14):1586-93. doi: 10.1177/0961203312458842. Epub 2012 Aug 30.

PMID:
22936126
33.

Population-based lupus registries: advancing our epidemiologic understanding.

Lim SS, Drenkard C, McCune WJ, Helmick CG, Gordon C, Deguire P, Bayakly R, Somers EC.

Arthritis Rheum. 2009 Oct 15;61(10):1462-6. doi: 10.1002/art.24835. No abstract available.

34.

A rare opportunistic infection in a woman with systemic lupus erythematosus and multiple skin lesions.

Hidron A, Franco-Paredes C, Drenkard C.

Lupus. 2009 Oct;18(12):1100-3. doi: 10.1177/0961203309105226.

PMID:
19762386
35.

Epidemiology of systemic lupus erythematosus: capturing the butterfly.

Lim SS, Drenkard C.

Curr Rheumatol Rep. 2008 Aug;10(4):265-72.

PMID:
18662505
36.

Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children.

Ramírez Gómez LA, Uribe Uribe O, Osio Uribe O, Grisales Romero H, Cardiel MH, Wojdyla D, Pons-Estel BA; Grupo Latinoamericano de Estudio del Lupus (GLADEL), Catoggio LJ, Soriano ER, Imamura PM, Manni JA, Grimaudo S, Sarano J, Maldonado-Cocco JA, Arriola MS, Gómez G, García MA, Marcos AI, Marcos JC, Scherbarth HR, Marino PC, Motta EL, Drenkard C, Gamron S, Buliubasich S, Onetti CM, Caeiro F, Alvarellos A, Saurit V, Gentiletti S, Quagliatto N, Gentiletti AA, Machado D, Abdala M, Palatnik S, Berbotto GA, Battagliotti CA, Sato E, Sella EM, Souza AS, Costallat LT, Bertolo MB, Coimbra IB, Borba Neto EF, Bonfá E, Tavares JC, Brenol, Xavier R, Mucenic T, Cavalcanti Fde S, Duarte AL, Marques CD, Da Silva NA, de O e Silva AC, Pacheco TF, Molina-Restrepo JF, Molina-López J, Iglesias-Gamarra A, Iglesias-Rodríguez A, Egea-Bermejo E, Guzmán-Moreno RA, Restrepo-Suárez JF, Guibert-Toledano M, Reyes-Llerena GA, Massardo L, Gareca N, Jacobelli S, Neira OJ, Guzmán LR, Garcia-Kutzbach A, Castellanos C, Cajas E, Pascual-Ramos V, Barile-Fabris LA, Miranda-Limón JM, Amigo MC, Silveira LH, De La Torre IG, Orozco-Barocio G, Estrada-Contreras ML, del Pozo MJ, Aranda Baca LE, Quezada AU, Huerta-Yáñez GF, Acevedo-Vásquez EM, Alfaro-Lozano JL, Cucho-Venegas JM, Segami MI, Chung CP, Alva-Linares M, Abadi I, Chacón-Díaz R, Al Snih Al Snih S, Esteva-Spinetti MH, Vivas J.

Lupus. 2008 Jun;17(6):596-604. doi: 10.1177/0961203307088006.

PMID:
18539716
37.

Obstructive uropathy as the only manifestation of flare in a patient with systemic lupus erythematosus and anti-phospholipid syndrome.

Asia S, Martellotto G, Belén R, Sesín AM, Gamróm S, Drenkard C.

Lupus. 2008 Jan;17(1):46-9.

PMID:
18089683
38.

Thrombocytopenia as a prognostic factor in Hispanic patients with systemic lupus erythematosus: comment on the article by Fernández et al.

Drenkard C, Villa AR.

Arthritis Rheum. 2007 Aug;56(8):2811-2; author reply 2812. No abstract available.

39.

[Hyperhomocystinemia as a thrombotic risk factor in patients suffering from systemic lupus erithematosus and antiphospholipid syndrome].

Onetti L, Villafañe S, Menso E, Drenkard C, Gamron S, Barberis G, Onetti CM.

Rev Fac Cien Med Univ Nac Cordoba. 2005;62(3):19-23. Spanish.

PMID:
16972729
40.

[Hyperhomocysteine like thrombocytic risk factor in patient with systemic lupus erythematous with antiphospholipid syndrome].

Onetti L, Villafañe S, Menso E, Drenkard C, Gamron S, Barberis G, Onetti CM.

Rev Fac Cien Med Univ Nac Cordoba. 2005;62(1):21-5. Spanish.

PMID:
16281418
41.

[Function of flow cytometry on the dosage of antibodies against double stranded DNA in systemic lupus erythematosus].

Ferrero PV, Drenkard C, Collino C, Cabral MJ, Gamron S, Barberis G, Onetti CM, Menso de Ezcurra EM.

Rev Alerg Mex. 2005 Jan-Feb;52(1):7-17. Spanish.

PMID:
15957468
42.

[Semester direct cost by rheumatoid arthritis in patients in a university hospital].

Audisio MJ, Strusberg I, Orellana Barrera SD, Drenkard CM, Barberis G, Gamrón S, Onetti CM.

Rev Fac Cien Med Univ Nac Cordoba. 2003;60(2):35-41. Spanish.

PMID:
14763431
43.

Survival of Mexican patients with systemic lupus erythematosus.

Alarcon-Segovia D, Drenkard C, Villa AR.

Rheumatology (Oxford). 2001 Feb;40(2):228-9. No abstract available.

PMID:
11257165
44.

Vasculitis and the antiphospholipid syndrome.

Alarcón-Segovia D, Drenkard C.

Rheumatology (Oxford). 2000 Aug;39(8):922-3. No abstract available.

PMID:
10952752
45.

The new prognosis of systemic lupus erythematosus: treatment-free remission and decreased mortality and morbidity.

Drenkard C, Alarcón-Segovia D.

Isr Med Assoc J. 2000 May;2(5):382-7. Review. No abstract available.

46.

Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.

Gómez-Pacheco L, Villa AR, Drenkard C, Cabiedes J, Cabral AR, Alarcón-Segovia D.

Am J Med. 1999 Apr;106(4):417-23.

PMID:
10225244
47.

Prevalence of 13 autoantibodies and of the 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity.

Villarreal GM, Drenkard C, Villa AR, Slor H, Shafrir S, Bakimer R, Shoenfeld Y, Alarcón-Segovia D.

Lupus. 1997;6(5):425-35.

PMID:
9229360
48.

Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).

Granados J, Vargas-Alarcón G, Drenkard C, Andrade F, Melín-Aldana H, Alcocer-Varela J, Alarcón-Segovia D.

Lupus. 1997;6(1):57-62.

PMID:
9116720
49.

Vasculitis in systemic lupus erythematosus.

Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D.

Lupus. 1997;6(3):235-42. Review.

PMID:
9104729
50.

Systemic lupus erythematosus in males. A study of 107 Latin American patients.

Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM, Gomez LJ, Felipe O, Ramirez LA, Alarcon-Segovia D.

Medicine (Baltimore). 1996 May;75(3):124-30. Review.

Supplemental Content

Loading ...
Support Center